RecruitingPhase 3NCT07228832
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Sponsor: Summit Therapeutics
Camden, NJ · New Brunswick, NJ · +110 more sites
Colorectal Cancer clinical trials in New Brunswick, NJ
8 recruiting colorectal cancer studies with a site in New Brunswick, NJ.
All trials in New Brunswick, NJ · All Colorectal Cancer trials
RecruitingPhase 2NCT07446322
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
Sponsor: Oncolytics Biotech
Florham Park, NJ · New Brunswick, NJ · +15 more sites
RecruitingPhase 1NCT05877599
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Sponsor: AstraZeneca
New Brunswick, NJ · +19 more sites
RecruitingPhase 1NCT06004245
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Sponsor: Vividion Therapeutics, Inc.
New Brunswick, NJ · +15 more sites
RecruitingPhase 1 / Phase 2NCT07488676
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.
Hackensack, NJ · New Brunswick, NJ · +16 more sites
RecruitingPhase 1NCT05433142
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Sponsor: Xencor, Inc.
New Brunswick, NJ · +19 more sites
RecruitingPhase 2NCT05806931
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
Sponsor: Rutgers, The State University of New Jersey
Elizabeth, NJ · Jersey City, NJ · Lakewood, NJ · +6 more sites
RecruitingPhase 4NCT07158164
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Sponsor: Rutgers, The State University of New Jersey
Belleville, NJ · Elizabeth, NJ · Hamilton, NJ · +9 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.